After earning my Medical degree from Maastricht University in 2017, I started working at Thoraxcentrum Twente as a resident in Cardiology. My career journey led me to pursue a Ph.D. at the University of Twente, focusing on interventional cardiology and earning the cum laude predicate upon graduation in 2021. My doctoral research focused on interventional cardiology, specifically exploring advancements in percutaneous coronary intervention techniques using drug-eluting stents.

Currently, I am a researcher for HTSR and Thoraxcentrum Twente while continuing my residency in cardiology. I am committed to improve cardiovascular care, contributing to both academia and clinical practice.

Expertise

  • Medicine and Dentistry

    • Patient
    • Stent
    • Drug-Eluting Stent
    • Percutaneous Coronary Intervention
    • Inpatient
    • Myocardial Infarction
    • Therapeutic Procedure
    • Chronic Obstructive Pulmonary Disease

Organisations

Publications

Jump to: 2024 | 2023 | 2022 | 2021

2024

Final 5-year report of BIONYX comparing the thin-composite wire-strut zotarolimus-eluting stent versus ultrathin-strut sirolimus-eluting stent (2024)Catheterization and cardiovascular interventions, 104(1), 1-9. van Vliet, D., Ploumen, E. H., Pinxterhuis, T. H., Buiten, R. A., Aminian, A., Schotborgh, C. E., Danse, P. W., Roguin, A., Anthonio, R. L., Benit, E., Zocca, P., Doggen, C. J. M. & von Birgelen, C.https://doi.org/10.1002/ccd.31067Ethnic minorities treated with new-generation drug-eluting coronary stents in two European randomised clinical trials (2024)Netherlands heart journal, 32(6), 254-261. Ploumen, E. H., Semedo, E., Doggen, C. J. M., Schotborgh, C. E., Anthonio, R. L., Danse, P. W., Benit, E., Aminian, A., Stoel, M. G., Hartmann, M., van Houwelingen, K. G., Scholte, M., Roguin, A., Linssen, G. C. M., Zocca, P. & von Birgelen, C.https://doi.org/10.1007/s12471-024-01873-9Ten-year mortality after treating obstructive coronary atherosclerosis with contemporary stents in patients with or without concomitant peripheral arterial disease (2024)Atherosclerosis, 392. Article 117488. Pinxterhuis, T. H., Ploumen, E. H., van Vliet, D., van Houwelingen, K. G., Stoel, M. G., de Man, F. H., Hartmann, M., Zocca, P., Linssen, G. C., Geelkerken, R. H., Doggen, C. J. & von Birgelen, C.https://doi.org/10.1016/j.atherosclerosis.2024.117488Invasiveness of previous treatment for peripheral arterial disease and risk of adverse cardiac events after coronary stenting (2024)Cardiovascular Intervention and Therapeutics, 39(2), 173-182. Pinxterhuis, T. H., von Birgelen, C., Geelkerken, R. H., Doggen, C. J. M., Menting, T. P., van Houwelingen, K. G., Linssen, G. C. M. & Ploumen, E. H.https://doi.org/10.1007/s12928-024-00986-7Lack of Evidence Regarding Markers Identifying Acute Heart Failure in Patients with COPD: An AI-Supported Systematic Review (2024)International journal of chronic obstructive pulmonary disease, 19, 531-541. van Dijk, S. H. B., Brusse-Keizer, M. G. J., Bucsán, C. C., Ploumen, E. H., van Beurden, W., van der Palen, J., Doggen, C. & Lenferink, A.https://doi.org/10.2147/COPD.S437899Data inputs and results from AI-supported title and abstract screening "Lack of evidence regarding markers identifying acute heart failure in patients with COPD: an AI-supported systematic review" (2024)[Dataset Types › Dataset]. Zenodo. van Dijk, S. H. B., Brusse-Keizer, M. G. J., Bucsán, C. C., Ploumen, E. H., van Beurden, W. J. C., van der Palen, J., Doggen, C. J. M. & Lenferink, A.https://doi.org/10.5281/zenodo.10517334Drug-coated balloons as a first choice for patients with de novo lesions: pros and cons (2024)EuroIntervention, 20(2), e120-e122. Colombo, A., Leone, P. P., Ploumen, E. H. & von Birgelen, C.https://doi.org/10.4244/EIJ-E-23-00034

2023

Exploring Patterns of COPD Exacerbations and Comorbid Flare-Ups (2023)International journal of chronic obstructive pulmonary disease, 18, 2633-2644. van Dijk, S. H. B., Brusse-Keizer, M., Effing, T., van der Valk, P. D. L. P. M., Ploumen, E., Palen, J. v. d., Doggen, C. J. M. & Lenferink, A.https://doi.org/10.2147/COPD.S428960First Myocardial Infarction in Patients with Premature Coronary Artery Disease: Insights into Patient Characteristics and Outcome after Treatment with Contemporary Stents (2023)European Heart Journal: Acute Cardiovascular Care, 12(11), 774-781. Pinxterhuis, T. H., Ploumen, E. H., Doggen, C. J. M., Hartmann, M., Schotborgh, C. E., Anthonio, R. L., Roguin, A., Danse, P. W., Benit, E., Aminian, A., Linssen, G. C. M. & Von birgelen, C.https://doi.org/10.1093/ehjacc/zuad098Biomarkers differentiating acute heart failure from COPD exacerbations: not much evidence (2023)European respiratory journal, 62, PA515. van dijk, S. H. B., Brusse-Keizer, M. G. J., Bucsán, C. C., Ploumen, E. H., van Beurden, W. J. C., van der Palen, J., Doggen, C. J. M. & Lenferink, A.https://doi.org/10.1183/13993003.congress-2023.PA515Exploring patterns of COPD exacerbations and comorbid flare-ups (2023)European respiratory journal, PA1348. van dijk, S. H. B., Brusse-Keizer, M. G. J., Effing, T., van der valk, P. D. L. P. M., Ploumen, E. H., van der Palen, J., Doggen, C. J. M. & Lenferink, A.https://doi.org/10.1183/13993003.congress-2023.PA1348Outcome of percutaneous coronary intervention using ultrathin-strut biodegradable polymer sirolimus-eluting versus thin-strut durable polymer zotarolimus-eluting stents in patients with comorbid peripheral arterial disease: a post-hoc analysis from two randomized trials (2023)Cardiovascular diagnosis and therapy, 13(4), 673-685. Pinxterhuis, T. H., Ploumen, E. H., Zocca, P., Doggen, C. J. M., Schotborgh, C. E., Anthonio, R. L., Roguin, A., Danse, P. W., Benit, E., Aminian, A., van Houwelingen, K. G., Linssen, G. C. M., Geelkerken, R. H. & von Birgelen, C.https://doi.org/10.21037/cdt-22-584Predictors of target lesion failure after treatment of left main, bifurcation, or chronic total occlusion lesions with ultrathin-strut drug-eluting coronary stents in the ULTRA registry (2023)Catheterization and cardiovascular interventions, 102(2), 221-232. de Filippo, O., Bruno, F., Pinxterhuis, T. H., Gąsior, M., Perl, L., Gaido, L., Tuttolomondo, D., Greco, A., Verardi, R., Lo Martire, G., Iannaccone, M., Leone, A., Liccardo, G., Caglioni, S., González Ferreiro, R., Rodinò, G., Musumeci, G., Patti, G., Borzillo, I., … D'Ascenzo, F.https://doi.org/10.1002/ccd.30696Impact of premature coronary artery disease on adverse event risk following first percutaneous coronary intervention (2023)Frontiers in Cardiovascular Medicine, 10. Article 1160201. Pinxterhuis, T. H., Ploumen, E. H., Zocca, P., Doggen, C. J. M., Schotborgh, C. E., Anthonio, R. L., Roguin, A., Danse, P. W., Benit, E., Aminian, A., Hartmann, M., Linssen, G. C. M. & von Birgelen, C.https://doi.org/10.3389/fcvm.2023.1160201Risk of bleeding after percutaneous coronary intervention and its impact on further adverse events in clinical trial participants with comorbid peripheral arterial disease (2023)International journal of cardiology, 374, 27-32. Pinxterhuis, T. H., Ploumen, E. H., Zocca, P., Doggen, C. J. M., Schotborgh, C. E., Anthonio, R. L., Roguin, A., Danse, P. W., Benit, E., Aminian, A., Stoel, M. G., Linssen, G. C. M., Geelkerken, R. H. & von Birgelen, C.https://doi.org/10.1016/j.ijcard.2022.12.009

2022

Final 5-Year Report of the Randomized BIO-RESORT Trial Comparing 3 Contemporary Drug-Eluting Stents in All-Comers (2022)Journal of the American Heart Association, 11(22). Article e026041. Ploumen, E. H., Pinxterhuis, T. H., Buiten, R. A., Zocca, P., Danse, P. W., Schotborgh, C. E., Scholte, M., Tjon Joe Gin, R. M., Somi, S., van Houwelingen, K. G., Stoel, M. G., de Man, H. A. F., Hartmann, M., Linssen, G. C. M., van der Heijden, L. C., Kok, M. M., Doggen, C. J. M. & von Birgelen, C.https://doi.org/10.1161/JAHA.122.026041Search for Holy Grail of Stent Coating Will Go On (2022)Cardiovascular Revascularization Medicine, 42, 100-101. Ploumen, E. H. & von Birgelen, C.https://doi.org/10.1016/j.carrev.2022.06.019Outcome after percutaneous coronary intervention with contemporary stents in patients with concomitant peripheral arterial disease: A patient-level pooled analysis of four randomized trials (2022)Atherosclerosis, 355, 52-59. Pinxterhuis, T. H., Ploumen, E. H., Zocca, P., Doggen, C. J. M., Schotborgh, C. E., Anthonio, R. L., Roguin, A., Danse, P. W., Benit, E., Aminian, A., Stoel, M. G., Linssen, G. C. M., Geelkerken, R. H. & von Birgelen, C.https://doi.org/10.1016/j.atherosclerosis.2022.05.002Prediction of All-Cause Mortality Following Percutaneous Coronary Intervention in Bifurcation Lesions Using Machine Learning Algorithms (2022)Journal of Personalized Medicine, 12(6). Article 990. Burrello, J., Gallone, G., Burrello, A., Pagliari, D. J., Ploumen, E. H., Iannaccone, M., De Luca, L., Zocca, P., Patti, G., Cerrato, E., Wojakowski, W., Venuti, G., De Filippo, O., Mattesini, A., Ryan, N., Helft, G., Muscoli, S., Kan, J., Sheiban, I., … D’ascenzo, F.https://doi.org/10.3390/jpm12060990Use of the left radial artery as vascular access for coronary angiography and as a bypass conduit: A clinical dilemma? (2022)Cardiovascular Revascularization Medicine, 34, 134-139. Ploumen, E. H., Halfwerk, F. R., van der Kolk, R., Grandjean, J. G., von Birgelen, C. & van Til, J. A.https://doi.org/10.1016/j.carrev.2021.01.014

2021

New-generation drug-eluting stents in various patient populations (2021)[Thesis › PhD Thesis - Research external, graduation UT]. University of Twente. Ploumen, E. H.https://doi.org/10.3990/1.9789036552523First Report of 3-Year Clinical Outcome After Treatment With Novel Resolute Onyx Stents in the Randomized BIONYX Trial (2021)Circulation Journal, 85(11), 1983-1990. Ploumen, E. H., Buiten, R. A., Zocca, P., Doggen, C., Aminian, A., Schotborgh, C. E., Jessurun, G. A. J., Roguin, A., Danse, P. W., Benit, E. & von Birgelen, C.https://doi.org/10.1253/circj.cj-21-0292Novel DES aims at full thromboresistance: Another promising player on the field? (2021)Cardiovascular Revascularization Medicine, 32, 25-26. Ploumen, E. H. & von Birgelen, C.https://doi.org/10.1016/j.carrev.2021.07.029Impact of prediabetes and diabetes on 3-year outcome of patients treated with new-generation drug-eluting stents in two large-scale randomized clinical trials (2021)Cardiovascular diabetology, 20(1). Article 217. Ploumen, E. H., Pinxterhuis, T. H., Zocca, P., Roguin, A., Anthonio, R. L., Schotborgh, C. E., Benit, E., Aminian, A., Danse, P. W., Doggen, C. J. M., von Birgelen, C. & Kok, M. M.https://doi.org/10.1186/s12933-021-01405-4Acute myocardial infarction treated with novel Resolute Onyx and Orsiro stents in the randomized BIONYX trial (2021)Catheterization and cardiovascular interventions, 98(2), E188-E196. Ploumen, E. H., Buiten, R. A., Zocca, P., Doggen, C., Jessurun, G. A. J., Schotborgh, C. E., Roguin, A., Danse, P. W., Benit, E., Aminian, A., Anthonio, R. L., Somi, S., Linssen, G. C. M., Hartmann, M., Kok, M. M. & von Birgelen, C.https://doi.org/10.1002/ccd.29594

Research profiles

Address

University of Twente

Ravelijn (building no. 10), room Flex
Hallenweg 17
7522 NH Enschede
Netherlands

Navigate to location

Organisations

Scan the QR code or
Download vCard